President and Fellows of Harvard College;The Brigham and Women's Hospital, Inc.;Trustees of Boston University;TUFTS UNIVERSITY
发明人:
申请号：
EP15002668.0
公开号：
EP3034494A1
申请日:
2008.08.15
申请国别(地区):
EP
年份:
2016
代理人:
摘要：
The invention features a series of heterocyclic derivatives that inhibit tumor necrosis factor alpha (TNF-α) induced necroptosis. The heterocyclic compounds of the invention are described by Formulas (I) and (Ia)-(Ie) and are shown to inhibit TNF-α induced necroptosis in FADD-deficient variant of human Jurkat T cells. The invention further features pharmaceutical compositions featuring the compounds of the invention. The compounds and compositions of the invention may also be used to treat disorders where necroptosis is likely to play a substantial role.
